Finnzymes是一家專注于開發(fā)的分子生物學(xué)儀器和試劑的芬蘭高科技公司。在超過20年的研發(fā)歷史，F(xiàn)innzymes不斷向用戶提供zui高質(zhì)量，*性能的產(chǎn)品。其產(chǎn)品主要涉及PCR，qPCR，轉(zhuǎn)錄子，RNA研究等領(lǐng)域，覆蓋40多個國家和地區(qū)。
Finnzymes Diagnostics develops reagents and provides testing services to customers in the microbial, forensic and veterinary -diagnostic research fields. The company is a sister operation of Finnzymes Oy （founded in 1986）, focusing on development of molecular biology reagents, and Finnzymes Instruments （founded in 2005）, developing instrumentation and reaction vessels for PCR based applications.

The products and services of Finnzymes Diagnostics are based on amplification of DNA using PCR or Real-Time PCR technologies. Key innovations of Finnzymes in these research areas, especially relating to novel DNA polymerases, lay the foundation for unparalleled sensitivity, speed and robustness of our diagnostic reagents and services.

Finnzymes Diagnostics operates under strict quality control protocols and has an ISO9001:2000 certification.

Finnzymes has been developing novel enzymes for molecular biology for the past 20 years. We develop reagents for PCR, transposon, and RNA technologies. Our mission is to provide tools of excellent quality and extreme purity to the scientific community; therefore research and development is a continuous process in our company. Our products are currently sold worldwide in more than 40 countries.

In addition to reagents for molecular biology, Finnzymes operates in three other main areas. Finnzymes Instruments develops instrumentation and reaction vessels for PCR-based applications. Finnzymes Diagnostics develops reagents and provides testing services to customers in the microbial, forensic, and veterinary-diagnostic research fields. Finnzymes is the leading company in Finland for distributing reagents and instrumentation for life science researchers.

Pioneering new technologies 
Our product offering includes a variety of DNA polymerases, providing a suitable enzyme for all purposes, ranging from routine PCR to the most demanding high-fidelity applications. PhusionT High-Fidelity DNA Polymerase utilizes a unique fusion technology. This exciting new technology provides accuracy and speed previously unattainable with any thermostable DNA polymerase. Quantitative PCR, in which amplification of the DNA target molecule is monitored in real time, is a growing trend. Finnzymes offers versatile and reliable DyNAmoT qPCR Kits for this technology for different platforms and chemistries.

Finnzymes has also been working several years in the field of transposon technology. TGST, MGST, and STOPT Kits are innovative MuA-based transposon products developed to facilitate DNA sequencing and functional analysis of proteins.

Gene silencing, by using small interfering RNA molecules, has become a widely used tool to study gene expression and networks of gene function. Finnzymes is proud to introduce novel tools for RNA research. The ReplicatorT RNAi Kit employs a method using an RNA-dependent RNA polymerase to generate a large amount of dsRNA. The resulting dsRNA can be cleaved to produce a pool of siRNAs.

Research collaboration 
We collaborate with several research groups and companies to refine scientific innovations into useful commercial products for molecular biologists worldwide. We work closely with New England Biolabs, a world leader in the production and supply of reagents for the life science industry.

Company values 
Finnzymes' philosophy is to follow ethical practices in order to ensure the welfare and equality of its employees, to protect the environment, and to promote the use of ecologically sustainable technologies.

公司:www.finnzymes.com